Annual CFO
-$7.29 M
+$3.93 M+35.06%
01 December 2023
Summary:
Revelation Biosciences annual cash flow from operations is currently -$7.29 million, with the most recent change of +$3.93 million (+35.06%) on 01 December 2023. REVB annual CFO is now -117.73% below its all-time high of $41.09 million, reached on 01 December 2019.REVB Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$9.26 M
-$6.78 M-273.46%
01 September 2024
Summary:
Revelation Biosciences quarterly cash flow from operations is currently -$9.26 million, with the most recent change of -$6.78 million (-273.46%) on 01 September 2024. Over the past year, it has dropped by -$7.25 million (-362.20%). REVB quarterly CFO is now -876.99% below its all-time high of -$947.50 thousand, reached on 31 December 2022.REVB Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$16.58 M
-$7.54 M-83.45%
01 September 2024
Summary:
Revelation Biosciences TTM cash flow from operations is currently -$16.58 million, with the most recent change of -$7.54 million (-83.45%) on 01 September 2024. Over the past year, it has dropped by -$9.29 million (-127.50%). REVB TTM CFO is now -595.88% below its all-time high of -$2.38 million, reached on 31 March 2021.REVB TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REVB Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -362.2% | -127.5% |
| 3 y3 years | - | -314.2% | -101.9% |
| 5 y5 years | -117.7% | - | - |
REVB Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +35.1% | -877.0% | at low | -166.0% | at low |
| 5 y | 5 years | -117.7% | +35.1% | -877.0% | at low | -595.9% | at low |
| alltime | all time | -117.7% | +35.1% | -877.0% | at low | -595.9% | at low |
Revelation Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.26 M(+273.5%) | -$16.58 M(+83.4%) |
| June 2024 | - | -$2.48 M(-12.7%) | -$9.04 M(+5.7%) |
| Mar 2024 | - | -$2.84 M(+41.7%) | -$8.55 M(+17.3%) |
| Dec 2023 | -$7.29 M(-35.1%) | -$2.00 M(+16.7%) | -$7.29 M(+16.9%) |
| Sept 2023 | - | -$1.72 M(-13.8%) | -$6.23 M(-0.2%) |
| June 2023 | - | -$1.99 M(+26.4%) | -$6.25 M(-21.6%) |
| Mar 2023 | - | -$1.58 M(+66.2%) | -$7.96 M(-29.0%) |
| Dec 2022 | -$11.22 M | -$947.50 K(-45.3%) | -$11.22 M(-14.7%) |
| Sept 2022 | - | -$1.73 M(-53.3%) | -$13.15 M(-3.7%) |
| June 2022 | - | -$3.71 M(-23.2%) | -$13.65 M(+0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$4.83 M(+67.8%) | -$13.54 M(+22.1%) |
| Dec 2021 | -$11.09 M(-127.0%) | -$2.88 M(+28.8%) | -$11.09 M(+35.1%) |
| Sept 2021 | - | -$2.23 M(-37.8%) | -$8.21 M(+37.4%) |
| June 2021 | - | -$3.60 M(+50.9%) | -$5.98 M(+150.9%) |
| Mar 2021 | - | -$2.38 M | -$2.38 M |
| Dec 2019 | $41.09 M(+26.1%) | - | - |
| Dec 2018 | $32.58 M(+34.4%) | - | - |
| Dec 2017 | $24.25 M(+109.1%) | - | - |
| Dec 2016 | $11.60 M(+33.8%) | - | - |
| Dec 2015 | $8.67 M | - | - |
FAQ
- What is Revelation Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Revelation Biosciences?
- What is Revelation Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Revelation Biosciences?
- What is Revelation Biosciences quarterly CFO year-on-year change?
- What is Revelation Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Revelation Biosciences?
- What is Revelation Biosciences TTM CFO year-on-year change?
What is Revelation Biosciences annual cash flow from operations?
The current annual CFO of REVB is -$7.29 M
What is the all time high annual CFO for Revelation Biosciences?
Revelation Biosciences all-time high annual cash flow from operations is $41.09 M
What is Revelation Biosciences quarterly cash flow from operations?
The current quarterly CFO of REVB is -$9.26 M
What is the all time high quarterly CFO for Revelation Biosciences?
Revelation Biosciences all-time high quarterly cash flow from operations is -$947.50 K
What is Revelation Biosciences quarterly CFO year-on-year change?
Over the past year, REVB quarterly cash flow from operations has changed by -$7.25 M (-362.20%)
What is Revelation Biosciences TTM cash flow from operations?
The current TTM CFO of REVB is -$16.58 M
What is the all time high TTM CFO for Revelation Biosciences?
Revelation Biosciences all-time high TTM cash flow from operations is -$2.38 M
What is Revelation Biosciences TTM CFO year-on-year change?
Over the past year, REVB TTM cash flow from operations has changed by -$9.29 M (-127.50%)